Navegar

Colección

Datos Estadísticas

Lista de

cabergoline
5
"Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance" (2010) García-Tornadú, I.;Ornstein, A.M.;Chamson-Reig, A. (...)Becu-Villalobos, D. Endocrinology. 151(4):1441-1450
"Novel medical therapies for pituitary tumors" (2010) Theodoropoulou, M.;Labeur, M.;Paez Pereda, M. (...)Stalla, G.K. Frontiers of Hormone Research. 38:158-164
"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40
"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40
"New perspectives in the treatment of cushing's syndrome" (2004) Labeur, M.; Arzt, E.; Stalla, G.K.; Péz-Pereda, M. Current Drug Targets: Immune, Endocrine and Metabolic Disorders. 4(4):335-342